CSIMarket
 
Kiora Pharmaceuticals Inc   (NASDAQ: KPRX)
 

Kiora Pharmaceuticals Inc's Suppliers Performance

KPRX's Supply Chain




 
KPRX Costs vs Sales of Suppliers Growth

• More on KPRX Suppliers






Kiora Pharmaceuticals Inc's Comment on Supply Chain


The company does not have contractual relationships with third-party manufacturers. It plans to use third-party suppliers previously engaged for manufacturing components of its products, including KIO-104 and KIO-301, as well as for other planned clinical trials.

Kiora Pharmaceuticals Inc's Comment on Supply Chain


The company does not have contractual relationships with third-party manufacturers. It plans to use third-party suppliers previously engaged for manufacturing components of its products, including KIO-104 and KIO-301, as well as for other planned clinical trials.







KPRX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Kiora Pharmaceuticals Inc 16.49 0.00 -10.99 13
SUBTOTAL 0.00 0.00 0.00 -


Sources: Kiora Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Kiora Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.